Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
Clinical trial NCT00882323 · UNKNOWN
Trial details
- NCT number
- NCT00882323
- Sponsor
- The Korean Society of Pediatric Hematology Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.